Top Markets
#1 Helium Helium +45.70%
#2 TENDIES TENDIES +42.44%
#3 Pons Pons +36.20%
#4 UnifAI Network UnifAI Network +19.28%
#5 Seeker Seeker +18.90%
#6 Songbird Songbird +12.44%
#7 OSK OSK +10.10%
#8 Bounce Bounce +9.81%
#9 DAPPOS DAPPOS +9.74%
#10 Lista DAO Lista DAO +8.75%
Coin of the day
Helium Helium
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Poseida Therapeutics, Inc. Poseida Therapeutics, Inc.

Poseida Therapeutics, Inc.

PSTX
Classifica tra le azioni #10560
Poseida Therapeutics, Inc., a San Diego-based clinical-stage biopharmaceutical... Poseida Therapeutics, Inc., a San Diego-based clinical-stage biopharmaceutical firm established in 2014, is dedicated to advancing novel therapeutic solutions for conditions with significant unmet medical needs. Its pipeline prominently features several advanced cell therapies. For instance, P-PSMA-101, an autologous CAR-T cell therapy, is currently undergoing Phase I clinical trials for individuals battling metastatic castrate-resistant prostate cancer (mCRPC). Additionally, Poseida is progressing two other CAR-T candidates through Phase I: P-BCMA-ALLO1 targets relapsed/refractory multiple myeloma, while P-MUC1C-ALLO1 is designed to address a variety of solid tumors, such as breast, ovarian, and other epithelial-derived malignancies. The company is further exploring allogeneic (off-the-shelf) CAR-T approaches with candidates like P-CD19CD20-ALLO1, aimed at B cell malignancies and certain autoimmune conditions, and P-BCMACD19-ALLO1, which is in preclinical development for multiple myeloma. Another allogeneic CAR-T, P-PSMA-ALLO1, is also being developed for mCRPC. Beyond cell therapies, Poseida's portfolio includes clinical-stage liver-directed gene therapies, specifically P-OTC-101 and P-FVIII-101, alongside other exploratory allogeneic dual CAR candidates. Collaborative efforts include a research and licensing agreement with Takeda Pharmaceutical Company Limited.
Prezzo delle azioni
$9.50
Ultima sincronizzazione: 2025-01-08
Capitalizzazione di mercato
$819.52M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
US
Scambia Poseida Therapeutics, Inc. (PSTX)

Categoria

Healthcare
Storico del prezzo dell'azione per Poseida Therapeutics, Inc. (PSTX)
Prezzo di chiusura più alto: $9.50 il 2025-01-01

Prezzo di chiusura più basso: $14.51 il 2020-07-01
Storico del prezzo dell'azione di Poseida Therapeutics, Inc. dal 2020 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2025 0.49%
2024 201.20%
2023 -41.30%
2022 -23.11%
2021 -33.50%
2020 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $542.09 38.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 44.13%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.53 -12.70%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $138.18 473.58%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $759.27 7.20%
CH